ITGBL1 and Hepatic fibrosis: We demonstrated that ITGBL1 stimulates hepatic stellate cells (HSCs) to promote liver fibrosis by activating the TGF-β pathway [9], and we also found that serum ITGBL1 levels in CHB patients were significantly higher than those in healthy controls [10].